EFPIA Newsletter 10 October 2019

Blogs     10 October 2019 Analysis: Would ‘Medicines for the Many’ lead to many medicines? Guest blog from Richard Torbett of ABPI on medicines access and availability in the UK Read more →         10 October 2019 How big is the need for cross-border access to clinical trials? Patients with rare tumours and other rare diseases are particularly in need for treatment options. In some cases, these... Read more →

Events     31 OCT 2019   LifeTime meets industry Basel, Switzerland LifeTime is developing a Roadmap that will show the path on how technology developments will be combined with disease... Learn more →       05 NOV 2019   Connecting Healthcare Debate Residence Palace, Rue de la Loi 175, 1000 Brussels Making connections can advance patient care and support the European economy at a time of significant change and challenge... Learn more →

	08 NOV 2019			Evidence-based expertise for better policy-making Brussels Expert panel on effective ways of investing in health end of mandate conference Learn more →

	12 DEC 2019			Joint EFPIA & EFGCP Multi-Stakeholder Workshop on Paediatric Unmet Medical Needs Amsterdam, The Netherlands The workshop will be the opportunity to exchange opinions and develop mutually acceptable criteria for joint and informed... Learn more →

What we are reading In AI We Trust? The Future of Genomic Medicine 01 October 2019  (GEN) Read more → Review of Progress on Antimicrobial Resistance 08 October 2019  (Chatham House) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe